← Eichor
Study identifier: NCT03993262 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis

Condition: Autoimmune Encephalitis  ·  Sponsor: Jena University Hospital

PhasePhase 2
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Autoimmune Encephalitis is a disorder of the central nervous system caused by bodily substances, called antibodies. Antibodies normally help the body to prevent infections. However, in this disorder, the antibodies turn against the body itself and especially against cells in the brain and disturb the normal brain function. They are therefore called autoantibodies. There is no specific therapy for patients with autoimmune encephalitis so far. At the moment, the symptoms are treated with approved medications such as cortisone and immunotherapies also used in oncology. These therapies are unspecified and aim to reduce the number of autoantibodies and to contain the autoimmune process. In this trial we aim to test a new therapy option: in this therapy the body cells producing autoantibodies will be specifically targeted by a substance called bortezomib. The trial addresses patients with severe autoimmune encephalitis. The aim of the trial is to evaluate the efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.

This description comes directly from the study's public registry record.

Talk to the study team

Christian Geis, Prof.  ·  +49 (0) 3641  ·  Christian.Geis@med.uni-jena.de

Jonathan Wickel, Dr.  ·  +49 (0) 3641  ·  Jonathan.Wickel@med.uni-jena.de

Always discuss trial participation with your own doctor first.

Locations (17)

Ludwig-Maximilians-Universität München, Klinikum GroßhadernMünchen, Bavaria, GermanyRecruiting
Universitätsklinikum WürzburgWürzburg, Bavaria, GermanyRecruiting
Universitätsklinikum Jena, Sektion Translationale Neuroimmunologie, Klinik für NeurologieJena, Germany, GermanyRecruiting
Medizinische Hochschule HannoverHanover, Niedersachen, GermanyRecruiting
Charité - Universitätsmedizin Berlin, Klinik für Neurologie mit Experimenteller NeurologieBerlin, GermanyRecruiting
Ruhr-Universität Bochum, St. Josef Hospital, Klinik für NeurologieBochum, GermanyRecruiting
University Hospital Düsseldorf, Clinic for NeurologyDüsseldorf, GermanyRecruiting
Universitätsklinikum Erlangen, Neurologische KlinikErlangen, GermanyRecruiting
Universitätsklinikum Essen (AöR), Klinik für NeurologieEssen, GermanyRecruiting
University Hospital Frankfurt (Main), Clinic for NeurologyFrankfurt, GermanyRecruiting
Universitätsmedizin Göttingen Georg-August-Universität, Klinik für NeurologieGöttingen, GermanyRecruiting
Universitätsmedizin Greifswald, Klinik und Poliklinik für NeurologieGreifswald, GermanyRecruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03993262